Homology Medicines Inc
NASDAQ:QTTB

Watchlist Manager
Homology Medicines Inc Logo
Homology Medicines Inc
NASDAQ:QTTB
Watchlist
Price: 3.46 USD 4.22% Market Closed
Market Cap: 42.6m USD

Relative Value

There is not enough data to reliably calculate the relative value of QTTB.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

QTTB Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
30.5
Median 5Y
231.7
Industry
7.9
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-9.9
Industry
24
Forward
-1.2
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-11.5
Industry
21.6
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-11.3
Industry
23.7
vs History
vs Industry
23
Median 3Y
6.5
Median 5Y
8
Industry
3.4
vs History
vs Industry
Median 3Y
-41
Median 5Y
222.4
Industry
8.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
22
vs Industry
22
Median 3Y
-2.4
Median 5Y
-8.4
Industry
6.7
Forward
0
vs History
22
vs Industry
20
Median 3Y
-2.4
Median 5Y
-8.1
Industry
7.2
Forward
0.1
vs History
22
vs Industry
24
Median 3Y
-2.3
Median 5Y
-9.6
Industry
8.2
vs History
22
vs Industry
19
Median 3Y
-2.3
Median 5Y
-9.4
Industry
6.7
vs History
vs Industry
Median 3Y
18.6
Median 5Y
27.9
Industry
5.7

Multiples Across Competitors

QTTB Competitors Multiples
Homology Medicines Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Homology Medicines Inc
NASDAQ:QTTB
42.2m USD 0 -0.7 0.1 0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 067 817 -161 919.3 -196 621.7 -194 378
US
Abbvie Inc
NYSE:ABBV
394.3B USD 6.6 167.9 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
172.8B USD 4.8 24.7 17.9 17.9
US
Gilead Sciences Inc
NASDAQ:GILD
150.5B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.3B USD 9.6 30.6 22.4 23.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.9 -527.7 -574.6 -559.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.1B USD 5.2 16.2 15.3 17.4
AU
CSL Ltd
ASX:CSL
88B AUD 3.7 19.4 13.1 16.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
56.7B USD 17.7 1 300.9 171.3 207.7
NL
argenx SE
XBRU:ARGX
47.5B EUR 15.3 36.1 62.5 64.3
P/S Multiple
Revenue Growth P/S to Growth
US
Homology Medicines Inc
NASDAQ:QTTB
Average P/S: 3 406 995.3
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 067 817
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.8
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.6
10%
1
US
E
Epizyme Inc
F:EPE
2 067.9
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.2
6%
0.9
AU
CSL Ltd
ASX:CSL
3.7
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.7
46%
0.4
NL
argenx SE
XBRU:ARGX
15.3
49%
0.3
P/E Multiple
Earnings Growth PEG
US
Homology Medicines Inc
NASDAQ:QTTB
Average P/E: 201.8
Negative Multiple: -0.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 919.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
167.9
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.7
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.6
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
9%
1.8
AU
CSL Ltd
ASX:CSL
19.4
11%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 300.9
N/A N/A
NL
argenx SE
XBRU:ARGX
36.1
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Homology Medicines Inc
NASDAQ:QTTB
Average EV/EBITDA: 36.8
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 621.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.9
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.4
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.3
11%
1.4
AU
CSL Ltd
ASX:CSL
13.1
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
171.3
N/A N/A
NL
argenx SE
XBRU:ARGX
62.5
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Homology Medicines Inc
NASDAQ:QTTB
Average EV/EBIT: 42.5
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 378 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.9
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.4
13%
1.3
AU
CSL Ltd
ASX:CSL
16.3
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
207.7
N/A N/A
NL
argenx SE
XBRU:ARGX
64.3
N/A N/A